# How to Read and Interpret an NIH Summary Statement An NIH summary statement is the written record of what a peer review panel said about your grant application, and reading it well means extracting the reviewers' actual concerns from their critiques, scores, and phrasing rather than reacting to the number alone. Done correctly, nih summary statement interpretation turns a one-time review into a roadmap for grant proposal planning, whether your application was funded, scored but not funded, or not discussed at all. This guide walks through what the document contains, what each part means, how experienced applicants decode the language, and how to convert critiques into a concrete revision plan. It also clears up a common confusion, because "summary statement" refers to more than one kind of NIH document. ## What an NIH Summary Statement Is (and What It Is Not) After your grant application is reviewed by a Scientific Review Group, often called a study section or a review panel, the scientific review administrator (the SRA, the federal staff member who runs the meeting) compiles the reviewers' written critiques and the meeting discussion into a single document. That document is the summary statement. It is released to the applicant through the eRA Commons electronic system after the review meeting, typically within a few weeks. Three things a summary statement is not are worth stating plainly, because new applicants routinely misread them: 1. **It is not a funding decision.** The summary statement comes from the peer review body. Funding decisions come later, from the advisory council and the institute or center director. A mediocre score has been rescued by a program's priorities before, and a good percentile has gone unfunded. 2. **It is not a personalized letter.** The prose is assembled from multiple reviewers' written assessments and the discussion at the meeting. The "voice" is the panel's, smoothed by the SRA. 3. **It is not a verdict on you as a scientist.** Panels review a written proposal, often without knowing who wrote it, and their judgments concern the document in front of them on that day. Experienced mentors describe the real skill as reading between the lines, which is the title of a well-known book chapter on this exact problem. Lyman, Stanton, and Pequegnat advise applicants to look past the surface politeness of reviewer prose to find the concerns the panel actually acted on, because not every criticism carries equal weight in the final score. ## Understanding NIH Summary Statements: The Review Process Behind the Document ![Flowchart of assignment, three assigned reviewers, study section meeting, scoring or streamlining, SRA compilation, then council and funding decision.](/article-images/illustrations/nih-summary-statement-interpretation-review-sequence.webp) A little process background makes the document much easier to interpret. Here is the standard sequence for most investigator-initiated applications such as an R01. 1. **Assignment.** NIH staff assign the application to a study section for scientific review and to an institute or center for potential funding. 2. **Assigned reviewers.** Typically three members of the panel are assigned as primary, secondary, and tertiary reviewers. Each writes a detailed critique before the meeting. Other panel members read the application too. 3. **The meeting.** The assigned reviewers present the application, the panel discusses it, and each voting member records a preliminary overall impact score. 4. **Scoring.** Members who consider the application competitive vote. Scores are averaged and rounded to produce the final overall impact score. Applications judged not competitive are "streamlined," meaning not scored and not discussed in detail. 5. **The summary statement.** The SRA compiles the critiques, the overall resume, the criterion scores, and the final overall impact score into the summary statement, which is released to the applicant in eRA Commons. 6. **Council and funding.** The advisory council of the relevant institute reviews the application and the summary statement, then the institute makes funding decisions subject to its budget. Knowing this sequence explains several features of the document that confuse first-time readers. The bullet points of strengths and weaknesses were drafted before the meeting, then revised afterward to reflect the discussion. The criterion scores reflect each individual reviewer's judgment. The overall impact score is the panel's collective judgment of the application's likelihood of making an important contribution, which is not the same as an average of the criterion scores. ## The Anatomy of a Summary Statement A typical summary statement runs many pages and follows a predictable structure. The table below summarizes each component and what an applicant should look for in it. | Component | What it contains | What to look for when reading | |--|--|--| | Administrative header | Application number, title, cycle, study section name, review meeting date | Confirm the correct study section reviewed the work. A mismatched panel is grounds for an appeal. | | Overall resume and description | A short synopsis of the application and the panel's overall judgment paragraph | The single most important paragraph in the document. It states the panel's bottom line. | | Criterion scores | A score of 1 (exceptional) to 9 (poor) for each of the five review criteria | Compare criterion scores against the prose. A low Approach score with mild prose means a specific, fixable problem. | | Overall impact score | The panel's merged score, on the same 1 to 9 scale, reported multiplied by 10 | This is the number that drives percentile and funding position. | | Critique of Significance through Environment | Detailed prose under each of the five review criteria, with bulleted strengths and weaknesses | Distinguish weaknesses the panel called major from minor polishing suggestions. | | Additional review considerations | Comments on human subjects protections, vertebrate animals, biohazards, resource sharing, and other items | These rarely drive the overall score but can block an award if left uncorrected. | | Reviewer resumes | Contributions of the three assigned reviewers, labeled with their panel member numbers | Tells you which reviewer said what, and how much weight each carried in the discussion. | The five scored criteria are Significance, Investigators, Innovation, Approach, and Environment. Approach, the quality and rigor of the experimental design, draws the most detailed criticism on most applications because it is the section reviewers can test line by line. ## NIH Summary Statement Interpretation: A Section-by-Section Method Interpreting the document well is a habit, not a talent. The following method, adapted from the guidance published for applicants and mentors, works for nearly any scored application. ### Start With the Overall Impact Paragraph Read the overall resume and impact paragraph first, before the criterion critiques. This paragraph is the panel's consensus statement of what the application is and why it received the score it did. Experience reading many statements shows that this paragraph almost always telegraphs the two or three concerns that actually set the score, while the critiques below contain far more comments than the panel weighted [1]. If the paragraph mentions feasibility, the preliminary data, or the investigative team, those themes drove the discussion. If it praises the model system but says nothing about the analysis plan, the analysis plan was probably not the problem. ### Read the Criterion Critiques in Order Work through Significance, Investigators, Innovation, Approach, and Environment in that order. Under each, separate the bulleted strengths from the bulleted weaknesses, then rank the weaknesses by how many reviewers raised them independently. A weakness raised by all three assigned reviewers is a panel-level finding. A weakness raised once, in passing, may be one person's taste. Language matters as much as content. Phrases such as "it is not clear whether" or "the application would benefit from" are invitations to clarify. Phrases such as "the hypothesis is not testable as written" or "the preliminary data do not support feasibility" are substantive objections that likely lowered a criterion score. Grant mentors teach applicants to tag every sentence of critique as either fatal, major, or minor, and to count how many of each appear. ### Compare the Three Reviewer Resumes Near the end of the document, each assigned reviewer's individual contribution is summarized under a panel member number. Reading these resumes next to the critiques tells you which reviewer emphasized which concern. This matters for two reasons. First, it tells you whether a criticism is a lone reviewer's hobbyhorse or a shared judgment. Second, if a reviewer's critique rests on a misunderstanding of your experimental design, that is exactly the kind of error that can justify a polite clarification in your resubmission introduction. ### Decode the Scores NIH uses a 9-point scoring scale on which 1 represents an exceptionally strong application and 9 represents a poor one. The five criterion scores and the overall impact score all use this scale, and the overall impact score is conventionally reported multiplied by 10. Beyond the raw number, many institutes convert the score to a percentile that compares the application with others reviewed by the same panel, and funding decisions depend on each institute's own payline and priorities in that cycle. Do not treat a particular number as a fixed threshold. The meaningful question is always where your application sat relative to the panel's other applications and relative to the institute's funding range in recent cycles. If your application was streamlined and never scored, the summary statement will contain the reviewers' written critiques but little or no meeting discussion, because the panel did not discuss it. Interpretation still matters enormously here, since the critiques tell you exactly what to fix before the next submission. ## Translating Critiques Into Grant Proposal Planning The summary statement earns its value only when it changes what you do next. Three planning activities follow directly from a careful reading. ### Triage the Weaknesses Build a three-column list. Column one contains every major weakness the panel raised. Column two contains your honest assessment of whether the criticism is valid, partially valid, or based on a misreading. Column three contains your response for each. Responses fall into four types: new data that resolve the concern, a revised design or analysis plan, a clearer explanation of something the application already contained, or a reasoned rebuttal. Most successful revisions rely heavily on the third type, because reviewers frequently miss material that was present but buried. Do not attempt to fix every comment. Panels reward applications that resolve the major concerns decisively over applications that add twenty superficial concessions and bury the science under new text. ### Make the Resubmission Decision Thoughtfully Most applicants revise and resubmit, and NIH review explicitly considers whether the resubmission addresses the previous critique. Your introduction should contain a paragraph-by-paragraph description of the changes made in response to the summary statement. This is also the stage where grant proposal planning pays off across the whole portfolio. If the panel's central objection concerns your model system or your career-stage independence rather than the writing, the honest response may be a rethought project for the next cycle rather than a patch on this one. Mentors who have studied how applicants use reviewer feedback consistently find that the applicants who engage with the critiques' intent, rather than their literal wording, produce stronger resubmissions. ### Talk to Your Program Official Your assigned program official at the funding institute can tell you how the application fared in council, whether the institute would welcome a resubmission, and whether funds exist for the topic in the coming cycles. The program official reads summary statements every day and can calibrate your interpretation against institutional reality. This conversation costs nothing and routinely reshapes resubmission strategy. The wider funding environment also belongs in your planning. NIH awards, once made, can face interruption or cancellation, and scientific societies have formally argued against unlawful grant terminations in position statements addressed to Congress [2]. A prudent applicant reads the summary statement for scientific feedback and simultaneously tracks institute priorities, budget news, and policy changes. ## Common Mistakes and Limitations Even experienced investigators misread summary statements. These are the errors that appear most often, and each has a practical remedy. - **Fixating on the number before the prose.** The overall impact score tells you the outcome. The critiques tell you the cause. Read the cause first. - **Treating every comment as equal.** Panels write many more comments than they weight. The overall resume and the criterion scores reveal which comments mattered. - **Arguing with a reviewer instead of with the science.** If a criticism reflects a misunderstanding, the fix is clearer writing in the resubmission, not indignation. - **Ignoring the additional review considerations.** Human subjects protections, vertebrate animal welfare, and contamination or biohazard sections draw their own comments. Leaving them uncorrected invites administrative holds later. - **Assuming the panel speaks for NIH.** A study section's judgments reflect one meeting, one roster, and one day of discussion. A different panel can reach a different conclusion about the same science. - **Resubmitting without changed substance.** Panels are expressly asked to evaluate whether the resubmission meaningfully addresses the earlier critique. Cosmetic edits read as cosmetic. - **Reading alone.** A mentor, a senior colleague, or a program official will see patterns in the language that you cannot see while defensive about your own work. One limitation deserves plain acknowledgment. A summary statement is one panel's assessment on one day, and individual applications vary enormously in circumstances, career stage, and institute context. For decisions about your specific application, supplement this general guidance with advice from your program official, your institutional grants office, and experienced mentors at your institution. ## A Note on the Other Kind of NIH Summary Statement ![Comparison table of the peer review summary statement, the consensus development conference statement, and the intramural program summary statement.](/article-images/illustrations/nih-summary-statement-interpretation-document-types.webp) People searching for help with "summary statements" sometimes land on the wrong document entirely, so a disambiguation is genuinely useful. NIH has used the phrase "summary statement" for at least three distinct document types. The first is the peer review document described throughout this article, which applicants receive after study section review. The second is the consensus development conference summary statement. For decades, NIH convened expert panels to produce consensus statements on clinical questions, and the published outputs were formally titled "Summary of an NIH consensus statement." Examples include the 1981 statement on carcinoembryonic antigen as a marker in cancer management, the 1991 statement on adjuvant therapy for colon and rectal cancer, and the 1993 statement on diagnosis and treatment of depression in late life [3][4][5]. Later conference summaries followed the same pattern, such as the 2006 statement from the first National Institutes of Health and Office of Rare Diseases conference on autosomal recessive polycystic kidney disease and congenital hepatic fibrosis [6]. These consensus documents summarize expert agreement on a clinical question. They have nothing to do with grant review, and no amount of grant-writing advice helps you interpret them. The third type is the intramural program summary statement, an annual administrative report in which an NIH laboratory or office describes its own activities and plans. Examples published in Environmental Health Perspectives include the 1977 summary statement of the Office of the Scientific Director at the [National Institute of Environmental Health Sciences](/blog/careers/national-institute-of-environmental-health-sciences-research-and-career-opportunities), which reported recruiting program leaders and preparing for Board of Scientific Counselors review, and the 1977 summary statement of the Laboratory of Environmental Mutagenesis, which described an intramural program in environmental mutagenesis, collaborative projects, and a solicitation for extramural grant proposals in specific emphasis areas [7][8]. These documents are internal program reports made public through the journal, not critiques of anyone's application. When you search, check which document you have. Grant applicants need the first type. ## Building the Skill Deliberately Summary statement reading is a learnable skill, and structured training accelerates it. A research [grant writing](/knowledge/molecular-biology/grant-writing) course typically includes mock study section exercises in which participants score real or anonymized applications, then compare their critiques against the actual summary statement. That comparison is the fastest calibration available, because it shows you what a trained panel noticed that you missed and what you flagged that the panel ignored. Many course directors assign exactly the chapter by Lyman, Stanton, and Pequegnat on reading between the lines, precisely because it teaches the inferential step that separates naive readers from effective ones [1]. Institutional resources complement formal courses. Most university grant offices keep deidentified summary statements from past faculty submissions and will pair junior investigators with senior mentors who have served on study sections. Asking to read several successful applications together with their summary statements teaches the correlation between panel language and funding outcome better than any abstract advice. Two habits complete the skill set. First, if you ever serve on a study section, take notes on how critiques are phrased and how discussion shifts the scores. Reviewer experience is the single best teacher of what reviewer language means. Second, keep an annotated copy of every summary statement you receive, marking which predictions you made before opening the document. Over a career, that annotation file becomes a personal map of how panels think. ## Frequently Asked Questions ### What does NIH summary statement interpretation mean? It means reading the critique document NIH sends after peer review and working out, from the prose and scores, which concerns actually drove the panel's judgment. The term covers both understanding the document's structure and inferring the reviewers' real priorities from their language. ### How long after the study section meeting do I get my summary statement? Usually a few weeks. The scientific review administrator needs time to compile the written critiques and revise them to reflect the meeting discussion before releasing the document in eRA Commons. ### What does a score of 5 mean on my summary statement? NIH scores run from 1 for an exceptionally strong application to 9 for a poor one, so a 5 sits near the middle of the scale. Whether a middle score funds depends on the panel's other applications, the percentile conversion, and the institute's payline that cycle. ### Does an unscored application mean my science was bad? No. Streamlined applications simply fell below the panel's discussion threshold at that meeting, which can reflect topic fit, competition, or panel composition as much as scientific quality. The written critiques still tell you what to strengthen before resubmission. ### Should I respond to every weakness in a resubmission? No. Fix the major, repeated concerns decisively and briefly acknowledge the minor ones. Resubmission introductions that address every comment indiscriminately tend to bury the substantive changes the panel actually asked for. ### Can I contact the reviewers who wrote my critiques? No. Reviewer identities are confidential and direct contact is not permitted. Route questions through your scientific review administrator or program official, who can clarify procedural issues and, where justified, advise on an appeal. ### What do I do if my summary statement contains a factual error about my application? Contact your scientific review administrator promptly in writing. Factual errors, such as a misstatement of the experimental design, can be corrected or noted, and a material misstatement of fact is one of the recognized grounds for an appeal of initial peer review. ### Is an NIH summary statement the same as an NIH consensus statement? No. A grant summary statement is the peer review critique of your application. A consensus statement is the published output of an NIH consensus development conference on a clinical question, such as the 1991 statement on adjuvant therapy for colorectal cancer, and serves an entirely different purpose [4]. ## Sources 1. [Reading Between the Lines of Your Summary Statement](https://doi.org/10.1007/978-1-4419-1454-5_9) 2. [Position statement: congress must put an end to unlawful NIH grant cancellations.](https://pubmed.ncbi.nlm.nih.gov/41173545/) 3. [Carcinoembryonic antigen: its role as a marker in the management of cancer. Summary of an NIH consensus statement.](https://pubmed.ncbi.nlm.nih.gov/6780032/) 4. [Adjuvant therapy for patients with colon and rectal cancer: summary of NIH consensus statement. National Cancer Institute and the Office of Medical Applications of Research of the National Institutes of Health.](https://pubmed.ncbi.nlm.nih.gov/1994879/) 5. [Diagnosis and treatment of depression in late life: summary of the NIH consensus statement.](https://pubmed.ncbi.nlm.nih.gov/8469089/) 6. [Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference.](https://pubmed.ncbi.nlm.nih.gov/16887426/) 7. [Office of the Scientific Director: Summary Statement](https://pubmed.ncbi.nlm.nih.gov/17539122/) 8. [Laboratory of Environmental Mutagenesis: Summary Statement](https://pubmed.ncbi.nlm.nih.gov/17539126/)